These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 18462650

  • 1. [The calcium sensitizer levosimendan gives superior results to dobutamine in postoperative low cardiac output syndrome].
    Levin RL, Degrange MA, Porcile R, Salvagio F, Blanco N, Botbol AL, Tanus E, del Mazo CD.
    Rev Esp Cardiol; 2008 May; 61(5):471-9. PubMed ID: 18462650
    [Abstract] [Full Text] [Related]

  • 2. [Hemodynamic effects of levosimendan compared with dobutamine in patients with low cardiac output after cardiac surgery].
    Alvarez J, Bouzada M, Fernández AL, Caruezo V, Taboada M, Rodríguez J, Ginesta V, Rubio J, García-Bengoechea JB, González-Juanatey JR.
    Rev Esp Cardiol; 2006 Apr; 59(4):338-45. PubMed ID: 16709386
    [Abstract] [Full Text] [Related]

  • 3. Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome.
    Schumann J, Henrich EC, Strobl H, Prondzinsky R, Weiche S, Thiele H, Werdan K, Frantz S, Unverzagt S.
    Cochrane Database Syst Rev; 2018 Jan 29; 1(1):CD009669. PubMed ID: 29376560
    [Abstract] [Full Text] [Related]

  • 4. [Hemodynamic effects of levosimendan following cardiac surgery].
    Alvarez J, Taboada M, Rodríguez J, Caruezo V, Bouzada M, Campaña O, Bascuas B, Pérez-Paz J, Ginesta V.
    Rev Esp Anestesiol Reanim; 2005 Jan 29; 52(7):389-94. PubMed ID: 16200918
    [Abstract] [Full Text] [Related]

  • 5. Haemodynamic effects of levosimendan for low cardiac output after cardiac surgery: a case series.
    Malliotakis P, Xenikakis T, Linardakis M, Hassoulas J.
    Hellenic J Cardiol; 2007 Jan 29; 48(2):80-8. PubMed ID: 17489345
    [Abstract] [Full Text] [Related]

  • 6. Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome.
    Uhlig K, Efremov L, Tongers J, Frantz S, Mikolajczyk R, Sedding D, Schumann J.
    Cochrane Database Syst Rev; 2020 Nov 05; 11(11):CD009669. PubMed ID: 33152122
    [Abstract] [Full Text] [Related]

  • 7. Prophylactic milrinone for the prevention of low cardiac output syndrome and mortality in children undergoing surgery for congenital heart disease.
    Burkhardt BE, Rücker G, Stiller B.
    Cochrane Database Syst Rev; 2015 Mar 25; 2015(3):CD009515. PubMed ID: 25806562
    [Abstract] [Full Text] [Related]

  • 8. Use of Levosimendan in Postoperative Setting After Surgical Repair of Congenital Heart Disease in Children.
    Amiet V, Perez MH, Longchamp D, Boulos Ksontini T, Natterer J, Plaza Wuthrich S, Cotting J, Di Bernardo S.
    Pediatr Cardiol; 2018 Jan 25; 39(1):19-25. PubMed ID: 28884218
    [Abstract] [Full Text] [Related]

  • 9. Intravenous levosimendan treatment is cost-effective compared with dobutamine in severe low-output heart failure: an analysis based on the international LIDO trial.
    Cleland JG, Takala A, Apajasalo M, Zethraeus N, Kobelt G.
    Eur J Heart Fail; 2003 Jan 25; 5(1):101-8. PubMed ID: 12559222
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial.
    Follath F, Cleland JG, Just H, Papp JG, Scholz H, Peuhkurinen K, Harjola VP, Mitrovic V, Abdalla M, Sandell EP, Lehtonen L, Steering Committee and Investigators of the Levosimendan Infusion versus Dobutamine (LIDO) Study.
    Lancet; 2002 Jul 20; 360(9328):196-202. PubMed ID: 12133653
    [Abstract] [Full Text] [Related]

  • 11. Levosimendan compared with dobutamine in low output patients.
    Nieminen MS.
    Minerva Anestesiol; 2003 Apr 20; 69(4):258-63. PubMed ID: 12766717
    [Abstract] [Full Text] [Related]

  • 12. Levosimendan in patients with low-output heart failure: lessons from the LIDO trial.
    Follath F.
    Ital Heart J; 2003 May 20; 4 Suppl 2():34S-38S. PubMed ID: 14635368
    [Abstract] [Full Text] [Related]

  • 13. Effects of levosimendan on systemic and regional hemodynamics in septic myocardial depression.
    Morelli A, De Castro S, Teboul JL, Singer M, Rocco M, Conti G, De Luca L, Di Angelantonio E, Orecchioni A, Pandian NG, Pietropaoli P.
    Intensive Care Med; 2005 May 20; 31(5):638-44. PubMed ID: 15812624
    [Abstract] [Full Text] [Related]

  • 14. Levosimendan for Hemodynamic Support after Cardiac Surgery.
    Landoni G, Lomivorotov VV, Alvaro G, Lobreglio R, Pisano A, Guarracino F, Calabrò MG, Grigoryev EV, Likhvantsev VV, Salgado-Filho MF, Bianchi A, Pasyuga VV, Baiocchi M, Pappalardo F, Monaco F, Boboshko VA, Abubakirov MN, Amantea B, Lembo R, Brazzi L, Verniero L, Bertini P, Scandroglio AM, Bove T, Belletti A, Michienzi MG, Shukevich DL, Zabelina TS, Bellomo R, Zangrillo A, CHEETAH Study Group.
    N Engl J Med; 2017 May 25; 376(21):2021-2031. PubMed ID: 28320259
    [Abstract] [Full Text] [Related]

  • 15. Inotropic agents and vasodilator strategies for acute myocardial infarction complicated by cardiogenic shock or low cardiac output syndrome.
    Unverzagt S, Wachsmuth L, Hirsch K, Thiele H, Buerke M, Haerting J, Werdan K, Prondzinsky R.
    Cochrane Database Syst Rev; 2014 Jan 02; (1):CD009669. PubMed ID: 24385385
    [Abstract] [Full Text] [Related]

  • 16. The effects of levosimendan in cardiac surgery patients with poor left ventricular function.
    De Hert SG, Lorsomradee S, Cromheecke S, Van der Linden PJ.
    Anesth Analg; 2007 Apr 02; 104(4):766-73. PubMed ID: 17377079
    [Abstract] [Full Text] [Related]

  • 17. [Efficacy and safety of intravenous levosimendan compared with dobutamine in decompensated heart failure].
    Wang L, Cui L, Wei JP, Li GP, Qi GX, Hao YM, Wang WZ, Li HM, Liu J, Jiang DJ, Zhang YD.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Jun 02; 38(6):527-30. PubMed ID: 21033135
    [Abstract] [Full Text] [Related]

  • 18. A randomized controlled trial of levosimendan to reduce mortality in high-risk cardiac surgery patients (CHEETAH): Rationale and design.
    Zangrillo A, Alvaro G, Pisano A, Guarracino F, Lobreglio R, Bradic N, Lembo R, Gianni S, Calabrò MG, Likhvantsev V, Grigoryev E, Buscaglia G, Pala G, Auci E, Amantea B, Monaco F, De Vuono G, Corcione A, Galdieri N, Cariello C, Bove T, Fominskiy E, Auriemma S, Baiocchi M, Bianchi A, Frontini M, Paternoster G, Sangalli F, Wang CY, Zucchetti MC, Biondi-Zoccai G, Gemma M, Lipinski MJ, Lomivorotov VV, Landoni G.
    Am Heart J; 2016 Jul 02; 177():66-73. PubMed ID: 27297851
    [Abstract] [Full Text] [Related]

  • 19. Comparison of Levosimendan versus Dobutamine in Patients with Moderate to Severe Left Ventricular Dysfunction Undergoing Off-pump Coronary Artery Bypass Grafting: A Randomized Prospective Study.
    Kandasamy A, Simon HA, Murthy P, Annadurai M, Ali MM, Ramanathan G.
    Ann Card Anaesth; 2017 Jul 02; 20(2):200-206. PubMed ID: 28393781
    [Abstract] [Full Text] [Related]

  • 20. Effect of Levosimendan on Low Cardiac Output Syndrome in Patients With Low Ejection Fraction Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass: The LICORN Randomized Clinical Trial.
    Cholley B, Caruba T, Grosjean S, Amour J, Ouattara A, Villacorta J, Miguet B, Guinet P, Lévy F, Squara P, Aït Hamou N, Carillion A, Boyer J, Boughenou MF, Rosier S, Robin E, Radutoiu M, Durand M, Guidon C, Desebbe O, Charles-Nelson A, Menasché P, Rozec B, Girard C, Fellahi JL, Pirracchio R, Chatellier G, -.
    JAMA; 2017 Aug 08; 318(6):548-556. PubMed ID: 28787507
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.